相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling
Gary Hattersley et al.
ENDOCRINOLOGY (2016)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture
Jay S. Magaziner et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
Felicia Cosman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis
Michael R. McClung et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Time Since Prior Fracture Is a Risk Modifier for 10-Year Osteoporotic Fractures
Lora M. Giangregorio et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Timing of Subsequent Fractures after an Initial Fracture
Tineke A. C. M. van Geel et al.
Current Osteoporosis Reports (2010)
Proximal Humeral Fracture as a Risk Factor for Subsequent Hip Fractures
Jeremiah Clinton et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2009)
Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population-Based Cohort Study of 169,145 Cases During 1977-2001
Peter Ryg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density
Richard Eastell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Long-term risk of incident vertebral fractures
Jane A. Cauley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Risk of subsequent fracture after low-trauma fracture in men and women
Jacqueline R. Center et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture
John T. Schousboe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use
AB Hodsman et al.
ENDOCRINE REVIEWS (2005)
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture
O Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2004)
The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis
R Marcus et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Risk of new vertebral fracture in the year following a fracture
R Lindsay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
